The first is to follow the procedure of the new coronavirus antigen detection reagents and the corresponding test items are temporarily included in the province's basic medical insurance medical service catalog. Participants' expenses incurred in designated primary medical institutions will be paid in accordance with the current regulations of the coordinating region,and the expenses incurred for the test reagents purchased at designated retail pharmacies can be paid by using the individual account. Provincial medical security departments with reference to the "Office of the National Medical Security Bureau on the local proposed temporary new new coronavirus antigen test items and related matters of opinion letter" (medical insurance office letter [2022] No. 11), continue to standardize and optimize the price policy of the public health care institutions to provide the new coronavirus antigen testing services. Pharmaceutical centralized purchasing agencies around the world to do a good job of the new coronavirus antigen test reagents on the network, and actively promote the network procurement and relying on the national unified health insurance information platform for information **** enjoy. At the same time, strengthen the measurement and monitoring, and collaborate to promote the price, procurement, payment and information system transformation work.
The second is the timely adjustment of the new crown treatment drugs included in the scope of payment of medical insurance. For the medicines transferred from the "Diagnostic and Treatment Program (Trial Implementation of the Ninth Edition)" and not in the basic medical insurance catalog, the provincial medical insurance departments should stop the payment of medical insurance on the date of the release of the "Diagnostic and Treatment Program (Trial Implementation of the Ninth Edition)". Provincial medical security departments should do a good job of listing new medicines on the network, and for medicines that have not yet been listed on the network, medical institutions are allowed to purchase them offline first for emergency use. Nematrexate/ritonavir tablets added to the "Diagnostic and Treatment Program (Trial Ninth Edition)" will be purchased by medical institutions according to the prices agreed upon between the enterprises and the relevant departments, and the medical insurance departments will make payments according to the regulations.
Strengthen the implementation of various policies, and do a good job of preventing and controlling the epidemic under the new situation of normalization of the medical security work
Medical security departments at all levels should be in accordance with the "National Medical Security Bureau of the Ministry of Finance on doing a good job of medical security of the epidemic of pneumonia infected with the new coronavirus notice" (State Medical Security Electricity 〔2020〕 No. 5) and other series of documents, to improve the work initiatives, and continue to implement the new coronavirus infection. Improve the work initiatives, and continue to implement policies such as comprehensive protection of medical expenses for diagnosed patients. Support the normal operation of medical institutions in areas with serious epidemics, and prepay part of the funds for the treatment of new coronavirus in accordance with the procedures when necessary. We will do a good job of protecting the cost of vaccine and vaccination for the new coronavirus, conscientiously implement the pricing policy for nucleic acid and antigen testing programs, and implement the settlement and reimbursement policy for "long-term prescription" and Internet-based diagnosis and treatment, so as to ensure that all epidemic prevention and control medical insurance policies are put into effect, reduce the number of times that insured patients have to go to healthcare institutions for consultation and dispensing of medicines, and effectively reduce the safety risk of the spread of epidemics. The risk of the spread of the epidemic. Source CCTV News Editor Lili